The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Share News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Feedback's Bleepa wins contract with CVS Equine division

Fri, 16th Jul 2021 15:02

(Alliance News) - Medical imaging technology company Feedback PLC on Friday said that CVS Group, provider of integrated veterinary services, has appointed Bleepa as its clinical communications platform for CVS's Equine Division.

Feedback's core product Bleepa is a medical imaging communications app, providing a tool to enable remote and secure communications between front-line clinicians and teams. Bleepa will be rolled-out across 20 equine specialist surgeries.

Feedback did not disclose the value of the contract.

The current agreement is expected to result in increased Bleepa users and provides scope for Feedback to have a broader relationship with CVS. Furthermore, this agreement highlights the scalability of Bleepa and the company's ability to target non-NHS markets by tailoring the platform accordingly.

Bleepa developed an image push capability that enables X-rays to be securely pushed from the X-Ray machine over a cellular network to the Bleepa platform. The platform then makes these images available to specialists for immediate review and discussion, allowing the correct treatment guidance for the injured animal to be communicated to the vet and be provided at first visit. This capability means that images can now be taken in any location and can be instantly shared with specialist colleagues for timely advice and guidance.

"Their validation of our technology and expertise demonstrates the flexibility of Bleepa within new markets. By purchasing Bleepa, CVS have evidenced a real commitment to empower their vets by connecting them with specialist colleagues at the point of care, ultimately resulting in excellent animal care at the touch of a button, anywhere in the world," said Chief Executive Tom Oakley.

Shares in Feedback were up 2.4% at 0.85 pence each in London on Friday afternoon.

By Amrit Sahota; newsroom@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.